Publications
Oncology Pharmaceuticals: Update on Trends, Deals, Valuations and
Players in the Market
An overview of the evolving marketplace for oncology transactions and drugs, updating statistics from a Torreya presentation at the Sachs Conference in September, 2019.
July 2022
Do Reverse Mergers Create Value?
A study of biotech reverse mergers and associated alternatives.
May 2022
An Update on Private Venture Financing Activity in the Life Sciences Sector: A Rapidly Changing Market
Update to our June 2021 analysis of the private venture market for life sciences companies.
April 2022
Biopharmaceutical Sector Update: Q1 2022
A review of biopharma market activity in the first quarter of 2022.
April 2022
Biopharmaceutical Sector Update: January 2022
A look ahead to the coming year in the context of recent market activity, including "Torreya's Ten Themes to Watch in 2022."
January 2022
The Pharma 1000: The World’s Most Valuable Pharmaceutical Companies
This presentation updates our 2020 report, providing an up-to-date look at the current state and emerging trends in the global pharmaceutical industry.
November 2021
Biopharmaceutical Sector Update: October 2021
Update on the evolving financing and deal environment during the ongoing COVID-19 pandemic.
October 2021
Biopharmaceutical Sector Update: September 2021
Evolving financing and deal environment during the ongoing COVID-19 pandemic.
September 2021
An Update on Private Venture Financing Activity in the Life Sciences Sector: The Evolving Role of Crossover Investors
Analysis of the private venture market for life sciences companies with a particular focus on crossover investors.
June 2021
Biopharmaceutical Sector Update: Market Outlook for 2021
A recap of the Top 10 Biopharmaceutical Industry Events of 2020 and forecast of what may come in 2021.
January 2021
Biopharmaceutical Sector Update
Evolving financing and deal environment during the ongoing COVID-19 pandemic.
October 2020
The Pharma 1000: The World’s Most Valuable Pharmaceutical Companies
A deep look at the current state and emerging trends in the global pharmaceutical industry.
September 2020
Biopharmaceutical Sector Update
Evolving financing and deal environment.
May 2020
COVID-19 and the Biopharmaceutical Sector
An outlook for the financing and deal environment.
April 2020
Digital Therapeutics and the Future of Pharma
An overview of the digital health and therapeutics landscape highlighting key trends and impacts on industry stakeholders.
February 2020
Acceleration of Biopharma Partnering Activity into China
Overview of evolving marketplace favorable to drug development and western partners.
December 2019
Creating Value through Intelligent Borrowing
Overview of the evolving landscape of the Life Sciences debt market.
First of a four part series.
November 2019
New Directions in Oncology Business Development
Presented at Sachs Associates, 19th Annual Biotech in Europe
Forum
Basel, Switzerland.
September 2019
Creating Value through China Partnering
Overview of burgeoning market for in-licensing of pharmaceutical products into China and advice on how to negotiate and structure China licensing transactions.
October 2018
The Future of the Global Pharmaceutical Industry
Torreya’s in-depth study of the future of the pharmaceutical industry reveals the sector is larger and faster-growing than previously thought.
October 2017
Generic Pharmaceutical Industry Yearbook
Presented at Generic Pharmaceutical Association (GPhA) 2016 Annual Meeting,
Orlando, Florida.
February 2016
Partnerships and Investing in the Life Sciences
Presented at 2015 Indiana Life Sciences Summit,
Indianapolis,
Indiana.
October 2015
Life Sciences Outlook for 2014
Presented at Texas Life Science Forum,
Houston, TX.
February 2014
Pharmaceutical Valuation Analysis in Pharmaceutical Licensing and M&A Transactions: A Tutorial
Presented at Torreya Partners Client Event,
Bridgewater, NJ.
January 2014
Life Sciences / Pharma Industry Outlook
Presented at 2012 Texas Life Science Venture Forum,
Houston, TX.
March 2012